0001144204-18-028860.txt : 20180515 0001144204-18-028860.hdr.sgml : 20180515 20180515160451 ACCESSION NUMBER: 0001144204-18-028860 CONFORMED SUBMISSION TYPE: 13F-HR PUBLIC DOCUMENT COUNT: 2 CONFORMED PERIOD OF REPORT: 20180331 FILED AS OF DATE: 20180515 DATE AS OF CHANGE: 20180515 EFFECTIVENESS DATE: 20180515 FILER: COMPANY DATA: COMPANY CONFORMED NAME: Knoll Capital Management, LP CENTRAL INDEX KEY: 0001325083 IRS NUMBER: 133476926 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: 13F-HR SEC ACT: 1934 Act SEC FILE NUMBER: 028-11424 FILM NUMBER: 18836321 BUSINESS ADDRESS: STREET 1: 5 EAST 44TH STREET STREET 2: 12TH FLOOR CITY: NEW YORK STATE: NY ZIP: 10017 BUSINESS PHONE: 212-808-7474 MAIL ADDRESS: STREET 1: 5 EAST 44TH STREET STREET 2: 12TH FLOOR CITY: NEW YORK STATE: NY ZIP: 10017 13F-HR 1 primary_doc.xml 13F-HR LIVE false false false 0001325083 XXXXXXXX 03-31-2018 03-31-2018 false Knoll Capital Management, LP

5 East 44th Street 12th floor New York NY 10017

13F HOLDINGS REPORT 028-11424 N Fred Knoll 646-590-3960 /s/ Fred Knoll New York NY 05-15-2018 0 13 97391 INFORMATION TABLE 2 infotable.xml Abeona Therapeutics Inc COM 00289Y107 33863 2359767 SH SOLE 2359767 0 0 Advaxis Inc. W EXP 07/15/201 007624117 45 112500 SH SOLE 112500 0 0 Aldeyra Therapeutics Inc COM 01438T106 931 124096 SH SOLE 124096 0 0 Ampio Pharmaceuticals Inc. COM 03209T109 8825 2595484 SH SOLE 2595484 0 0 Anavex Life Sciences Corp COM NEW 032797300 1999 724205 SH SOLE 724205 0 0 Biohaven Pharmactl Hldg Co L COM G11196105 19315 749815 SH SOLE 749815 0 0 Corbus Pharmaceuticals HLDGS COM 21833P103 23528 3856985 SH SOLE 3856985 0 0 Eiger Biopharmaceuticals Inc COM 28249U105 741 75238 SH SOLE 75238 0 0 Evoke Pharma Inc COM 30049G104 572 275000 SH SOLE 275000 0 0 Krystal Biotech Inc COM 501147102 3027 300000 SH SOLE 300000 0 0 Soligenix Inc. COM 834223307 1638 837800 SH SOLE 837800 0 0 Vascular Biogenics LTD COM M96883109 2063 896771 SH SOLE 896771 0 0 Volition RX LTD COM 928661107 844 351538 SH SOLE 351538 0 0